Trial intelligence / Profile preview

Durability and booster effects of type I + III oral attenuated poliovirus vaccine (liquid/sugar pill, KMB17) with sequential IPV

CTR20171043Phase 3Active

Sponsor
Institute of Medical Biology Chinese Academy of Medical Sciences
Start
Dec 2017
Modality
Vaccines & Immunotherapeutics
Countries
1
01

Overview

A Phase 3 trial of bivalent oral poliovirus vaccine in poliomyelitis, sponsored by Institute of Medical Biology Chinese Academy of Medical Sciences. Started Dec 2017; status: active.

02

Drugs

bivalent oral poliovirus vaccine
03

Conditions

poliomyelitis

Beyond the preview

Go deeper on CTR20171043.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20171043.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call